SCHEMBL20150438

SCHEMBL20150438

Cc1cccc(-c2ccc3c4ccc(-c5cccc(C)c5)cc4n(-c4ccc(-c5nc(C)nc(C)n5)c(C#N)c4)c3c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
MAPK1 P28482 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
AR P10275 1/20 0.39
LRRK2 Q5S007 2/20 0.35
KDM4A O75164 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NR3C1 P04150 1/20 0.35
KDM4E B2RXH2 2/20 0.35
S1PR4 O95977 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
S1PR1 P21453 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
TSHR P16473 2/20 0.34
IMPDH2 P12268 1/20 0.34
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20155970 0.96 ALDH1A1 (0.39) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20155968 0.92 AR (0.41) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20156163 0.91 ALDH1A1 (0.46) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20114714 0.91 ALDH1A1 (0.36) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20156265 0.91 ALDH1A1 (0.39) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL21116168 0.89 AR (0.45) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20156129 0.89 ALDH1A1 (0.37) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20150421 0.88 ALDH1A1 (0.44) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20155972 0.88 ALDH1A1 (0.39) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL20156287 0.88 GRM2 (0.34) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 ALDH1A1 387/4885HPGD 2446/4885MAPK1 1664/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 ALDH1A1 387/4885HPGD 2446/4885MAPK1 1664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.